98%
921
2 minutes
20
Background/objectives: Cystoscopy is necessary for diagnosing bladder cancer, but it has limitations in identifying ambiguous lesions, such as carcinoma in situ (CIS), which leads to a high recurrence rate of bladder cancer. With the significant advancements in deep learning in the medical field, several studies have explored its application in cystoscopy. This study aimed to utilize the VGG19 and Deeplab v3+ deep learning models to classify and segment cystoscope images, respectively.
Methods: We classified cystoscope images obtained from 772 patients based on morphology (normal, papillary, flat, mixed) and biopsy results (normal, Ta, T1, T2, CIS, etc.). Experienced urologists annotated and labeled the lesion areas and image categories. The classification model for bladder cancer lesion, annotated with pathological results, was developed using VGG19 with an additional fully connected layer, utilizing sparse categorical cross-entropy as the loss function. The Deeplab v3+ model was used for segmenting each morphological type of bladder cancer in the cystoscope images, employing the dice coefficient loss function. The classification model was evaluated using validation accuracy and correlation with biopsy results, while the segmentation model was assessed using the Intersection over Union (IoU) combined with binary accuracy.
Results: The dataset was split into training and validation sets with a 4:1 ratio. The VGG19 classification model achieved an accuracy score of 0.912. The Deeplab v3+ segmentation model achieved an IoU of 0.833 and a binary accuracy of 0.951. Visual analysis revealed a high similarity between the lesions identified by Deeplab v3+ and those labeled by experts.
Conclusions: In this study, we applied two deep learning models using well-annotated datasets of cystoscopic images. Both VGG19 and Deeplab v3+ demonstrated high performance in classification and segmentation, respectively. These models can serve as valuable tools for bladder cancer research and may aid in the diagnosis of bladder cancer.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11718790 | PMC |
http://dx.doi.org/10.3390/cancers17010057 | DOI Listing |
JCO Clin Cancer Inform
September 2025
USC Institute of Urology and Catherine and Joseph Aresty Department of Urology, Keck School of Medicine, University of Southern California, Los Angeles, CA.
Purpose: To evaluate a generative artificial intelligence (GAI) framework for creating readable lay abstracts and summaries (LASs) of urologic oncology research, while maintaining accuracy, completeness, and clarity, for the purpose of assessing their comprehension and perception among patients and caregivers.
Methods: Forty original abstracts (OAs) on prostate, bladder, kidney, and testis cancers from leading journals were selected. LASs were generated using a free GAI tool, with three versions per abstract for consistency.
Am J Case Rep
September 2025
Department of Gastroenterology, Beijing Friendship Hospital, Capital Medical University; State Key Laboratory for Digestive Health; National Clinical Research Center for Digestive Diseases, Beijing, China.
BACKGROUND Non-traumatic bladder rupture, a rare yet potentially life-threatening condition, can stem from diverse factors such as malignancies, bladder inflammation, or bladder diverticulum rupture. Pelvic radiotherapy, in extremely rare instances, can lead to radiation cystitis and subsequent bladder fistula formation. Patients with such conditions often present with abdominal pain, hematuria, oliguria, and urinary ascites.
View Article and Find Full Text PDFInt J Surg
September 2025
Guangxi Medical University, Nanning, Guangxi, China.
World J Urol
September 2025
Uro-Oncology Program, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
Purpose: We aimed to evaluate the impact of day- and night-time pad wetness on 2yrs-QoL after Radical Cystectomy (RC) with Orthotopic Neobladder (ON) from a Randomized Controlled Trial (RCT) aimed at comparing open RC (ORC) and Robot-Assisted RC (RARC) with intracorporeal (i) ON.
Methods: Between January 2018 and September 2020, 116 patients were enrolled. Data from self-assessed questionnaires (EORTC-QLQ-C30 and QLQ-BLM30) were collected.
Elife
September 2025
Department of Urology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Immunogenic cell death (ICD) is a type of cell death sparking adaptive immune responses that can reshape the tumor microenvironment. Exploring key ICD-related genes in bladder cancer (BLCA) could enhance personalized treatment. The Cancer Genome Atlas (TCGA) BLCA patients were divided into two ICD subtypes: ICD-high and ICD-low.
View Article and Find Full Text PDF